AKT1 and lung carcinoma: While our results indicate that nestin acts through the Akt-GSK3β-Rb signaling pathway to contribute to proliferation in lung cancer cells, other aspects of tumor malignancy, such as angiogenesis, lymphangiogenesis and tumor metabolism, are yet to be directly examined.